These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8043911)

  • 21. The factor VIIa/tissue factor complex.
    Banner DW
    Thromb Haemost; 1997 Jul; 78(1):512-5. PubMed ID: 9198205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
    Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
    Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
    Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the interaction of tissue factor/factor VII with factor X in a heterogeneous tubular reactor.
    Gemmell CH; Turitto VT; Nemerson Y
    Thromb Haemost; 1991 Feb; 65(2):139-43. PubMed ID: 2053099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
    Jiang X; Guo YL; Bromberg ME
    Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor: regulation of activity by flow and phospholipid surfaces.
    Andree HA; Nemerson Y
    Blood Coagul Fibrinolysis; 1995 May; 6(3):189-97. PubMed ID: 7654932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an oriented transmembrane protein to probe the assembly of a supported phospholipid bilayer.
    Contino PB; Hasselbacher CA; Ross JB; Nemerson Y
    Biophys J; 1994 Sep; 67(3):1113-6. PubMed ID: 7811922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
    Butenas S; Brummel KE; Branda RF; Paradis SG; Mann KG
    Blood; 2002 Feb; 99(3):923-30. PubMed ID: 11806995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.
    Komiyama Y; Pedersen AH; Kisiel W
    Biochemistry; 1990 Oct; 29(40):9418-25. PubMed ID: 2248955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
    Hoffman M; Monroe DM; Roberts HR
    Blood; 1994 Jan; 83(1):38-42. PubMed ID: 8274750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the kinetics of factor X activation by tissue factor-factor VIIA.
    Nemerson Y
    Haemostasis; 1996 Oct; 26 Suppl 4():98-101. PubMed ID: 8979116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor.
    Gir S; Reavis R; Turitto VT; Gollamudi R
    Biotechnol Appl Biochem; 1996 Feb; 23(1):63-6. PubMed ID: 8867897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells.
    Hall CL; Slack SM; Turitto VT
    Ann Biomed Eng; 1998; 26(1):28-36. PubMed ID: 10355548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions.
    Grabowski EF; Zuckerman DB; Nemerson Y
    Blood; 1993 Jun; 81(12):3265-70. PubMed ID: 8507863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface.
    Gentry R; Ye L; Nemerson Y
    Biophys J; 1995 Aug; 69(2):362-71. PubMed ID: 8527649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow as a regulator of the activation of factor X by tissue factor.
    Gemmell CH; Turitto VT; Nemerson Y
    Blood; 1988 Oct; 72(4):1404-6. PubMed ID: 3262388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.